"We will focus on the qualitative aspect of weight loss with minimal muscle loss. In addition, we will focus on novel targets ...

Has there ever been a drug that's sparked this much controversy? It's the weight loss drug, Wegovy. For people struggling ...

A, a real loss insurance subscriber, was diagnosed with "obesity" and "hyperlipidemia" at the hospital and underwent ...

On the 26th, the bio and healthcare sector saw remarkable momentum: Bridge Biotherapeutics hit its upper limit for four ...

"근손실을 최소화 한 체중 감량의 질적인 면에 집중할 것이다. 여기에 GLP-1 외 신규 타깃에 집중해 새로운 작용기전(MOA)를 가진 비만 신약 개발도 함께 해 나갈 것이다."GLP-1 계열 약제의 상업화는 물론 신규 ...

Yuhan Corp. is exploring various collaborative strategies to develop new obesity drugs. In addition to securing the ...

The KOSPI and KOSDAQ indexes broke their annual highs on the 15th. KOSDAQ, which has not shown a remarkable rise in stock ...

South Korea’s biopharma stock market drew investor attention on July 7 with notable price movements from Ildong Pharmaceutical, Hyundai Bioscience, ...

Caregen Co. announced on July 15 that its weight loss health functional food "Korglutide" has received official registration approval from Ecuador’s health authority (National Agency for Regulation, C ...